Cargando…

Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study

BACKGROUND: This is a study aimed at exploring the relationship between pretreatment overweight/obesity, adipose tissue distribution, and long-term prognosis of gastric cancer. METHODS: A total of 607 gastric cancer patients were involved in the retrospective cohort study. Overweight/obese patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Lihu, Zhang, Yangfan, Hong, Jiaze, Xu, Binbin, Yang, Liuqiong, Yan, Kun, Zhang, Jingfeng, Chen, Ping, Zheng, Jianjun, Lin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264507/
https://www.ncbi.nlm.nih.gov/pubmed/34249721
http://dx.doi.org/10.3389/fonc.2021.680190
_version_ 1783719572933705728
author Gu, Lihu
Zhang, Yangfan
Hong, Jiaze
Xu, Binbin
Yang, Liuqiong
Yan, Kun
Zhang, Jingfeng
Chen, Ping
Zheng, Jianjun
Lin, Jie
author_facet Gu, Lihu
Zhang, Yangfan
Hong, Jiaze
Xu, Binbin
Yang, Liuqiong
Yan, Kun
Zhang, Jingfeng
Chen, Ping
Zheng, Jianjun
Lin, Jie
author_sort Gu, Lihu
collection PubMed
description BACKGROUND: This is a study aimed at exploring the relationship between pretreatment overweight/obesity, adipose tissue distribution, and long-term prognosis of gastric cancer. METHODS: A total of 607 gastric cancer patients were involved in the retrospective cohort study. Overweight/obese patients were defined as body mass index (BMI) greater than 25 kg/m(2), and adipose tissue distribution parameters, including visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and VAT/SAT ratio were measured at the level of the third lumbar vertebra using computerized tomography images within 15 days before the surgery. Multiple Cox regression models were applied to evaluate the association between overweight/obesity and disease-specific survival (DSS) of gastric cancer, and covariates including age, gender, T stage, N stage, and chemotherapy were adjusted. Furthermore, multiple Cox regression models were performed to evaluate the association between adipose tissue distribution parameters and DSS of gastric cancer; except for covariates mentioned above, overweight/obesity was adjusted additionally. RESULTS: Overweight/obesity was a predictive factor (HR = 0.61, 95% CI: 0.37–0.99) for the prognosis of gastric cancer. After additionally adjusting for overweight/obesity, high SAT percentage was an independent protective factor (HR = 0.59, 95% CI: 0.36–0.96), while high VAT percentage (HR = 1.68, 95% CI: 1.06–2.68) and high VAT/SAT ratio (HR = 1.99, 95% CI: 1.19–3.34) were independent risk factors for DSS of gastric cancer. Compared with other patients (overweight/obesity with low VAT/SAT ratio group, non-overweight/obesity or high VAT/SAT ratio group), patients in the non-overweight/obesity with high VAT/SAT ratio group had a worse prognosis (HR = 1.89, 95% CI: 1.28–2.77). CONCLUSION: These results suggest that overweight/obesity is a predictive factor for the prognosis of gastric cancer. The VAT/SAT ratio could be used as a promising prognostic factor for gastric cancer. Therefore, in preoperative evaluation of gastric cancer patients, attention should be paid not only to BMI but also to adipose tissue distribution.
format Online
Article
Text
id pubmed-8264507
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82645072021-07-09 Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study Gu, Lihu Zhang, Yangfan Hong, Jiaze Xu, Binbin Yang, Liuqiong Yan, Kun Zhang, Jingfeng Chen, Ping Zheng, Jianjun Lin, Jie Front Oncol Oncology BACKGROUND: This is a study aimed at exploring the relationship between pretreatment overweight/obesity, adipose tissue distribution, and long-term prognosis of gastric cancer. METHODS: A total of 607 gastric cancer patients were involved in the retrospective cohort study. Overweight/obese patients were defined as body mass index (BMI) greater than 25 kg/m(2), and adipose tissue distribution parameters, including visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and VAT/SAT ratio were measured at the level of the third lumbar vertebra using computerized tomography images within 15 days before the surgery. Multiple Cox regression models were applied to evaluate the association between overweight/obesity and disease-specific survival (DSS) of gastric cancer, and covariates including age, gender, T stage, N stage, and chemotherapy were adjusted. Furthermore, multiple Cox regression models were performed to evaluate the association between adipose tissue distribution parameters and DSS of gastric cancer; except for covariates mentioned above, overweight/obesity was adjusted additionally. RESULTS: Overweight/obesity was a predictive factor (HR = 0.61, 95% CI: 0.37–0.99) for the prognosis of gastric cancer. After additionally adjusting for overweight/obesity, high SAT percentage was an independent protective factor (HR = 0.59, 95% CI: 0.36–0.96), while high VAT percentage (HR = 1.68, 95% CI: 1.06–2.68) and high VAT/SAT ratio (HR = 1.99, 95% CI: 1.19–3.34) were independent risk factors for DSS of gastric cancer. Compared with other patients (overweight/obesity with low VAT/SAT ratio group, non-overweight/obesity or high VAT/SAT ratio group), patients in the non-overweight/obesity with high VAT/SAT ratio group had a worse prognosis (HR = 1.89, 95% CI: 1.28–2.77). CONCLUSION: These results suggest that overweight/obesity is a predictive factor for the prognosis of gastric cancer. The VAT/SAT ratio could be used as a promising prognostic factor for gastric cancer. Therefore, in preoperative evaluation of gastric cancer patients, attention should be paid not only to BMI but also to adipose tissue distribution. Frontiers Media S.A. 2021-06-24 /pmc/articles/PMC8264507/ /pubmed/34249721 http://dx.doi.org/10.3389/fonc.2021.680190 Text en Copyright © 2021 Gu, Zhang, Hong, Xu, Yang, Yan, Zhang, Chen, Zheng and Lin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gu, Lihu
Zhang, Yangfan
Hong, Jiaze
Xu, Binbin
Yang, Liuqiong
Yan, Kun
Zhang, Jingfeng
Chen, Ping
Zheng, Jianjun
Lin, Jie
Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study
title Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study
title_full Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study
title_fullStr Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study
title_full_unstemmed Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study
title_short Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study
title_sort prognostic value of pretreatment overweight/obesity and adipose tissue distribution in resectable gastric cancer: a retrospective cohort study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264507/
https://www.ncbi.nlm.nih.gov/pubmed/34249721
http://dx.doi.org/10.3389/fonc.2021.680190
work_keys_str_mv AT gulihu prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT zhangyangfan prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT hongjiaze prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT xubinbin prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT yangliuqiong prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT yankun prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT zhangjingfeng prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT chenping prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT zhengjianjun prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy
AT linjie prognosticvalueofpretreatmentoverweightobesityandadiposetissuedistributioninresectablegastriccanceraretrospectivecohortstudy